Immuno-Oncology Viral Platform
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
72
NCT06977737
A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 21, 2025
Completion: Dec 31, 2034
Loading map...